In a female rat model of polycystic ovary syndrome with impaired glucose tolerance and elevated plasma insulin, EPO treatment improved glucose tolerance, decreased serum insulin levels, and reduced disease-associated reproductive manifestations, although to a lesser extent than metformin [65]. The gene discussed is INS; the disease is Impaired glucose tolerance.